- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/52 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 263/52
Total number of patents in this class: 158
10-year publication summary
9
|
8
|
12
|
14
|
8
|
10
|
6
|
9
|
7
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2709 |
6 |
LG Chem, Ltd. | 17638 |
5 |
Janssen Pharmaceutica N.V. | 3383 |
5 |
Enanta Pharmaceuticals, Inc. | 428 |
5 |
Neumedics | 6 |
4 |
Shaanxi Lighte Optoelectronics Material Co., Ltd. | 260 |
4 |
Merck Sharp & Dohme LLC | 3741 |
4 |
Advancion Corporation | 110 |
4 |
Bayer Cropscience AG | 2036 |
3 |
Commissariat à l'énergie atomique et aux energies alternatives | 10912 |
3 |
Case Western Reserve University | 1822 |
3 |
Georgetown University | 611 |
3 |
Musc Foundation for Research Development | 349 |
3 |
Raqualia Pharma Inc. | 122 |
3 |
Rohm and Haas Electronic Materials Korea Ltd. | 330 |
3 |
Chromatwist Limited | 8 |
3 |
AstraZeneca AB | 2908 |
2 |
President and Fellows of Harvard College | 5976 |
2 |
Georgia Tech Research Corporation | 2736 |
2 |
Angus Chemical Company | 105 |
2 |
Other owners | 89 |